Loading company…
SpectraWAVE develops intravascular imaging devices for coronary artery procedures.
Founded in 2017 and based in Bedford, SpectraWAVE develops imaging technology for coronary artery procedures. Its HyperVue Imaging System combines DeepOCT and near-infrared spectroscopy to show plaque inside arteries and help guide stent placement. In September 2024, the company raised USD 49.31 million in Series B funding led by Johnson & Johnson Innovation, Deerfield Management, S3 Ventures, Lumira Ventures, SV Health Investors, and Nova Venture Partners, LLC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in